Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

This session examines the current state of progress toward a functional cure for HIV, drawing on advances in immunology, ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Carvykti sales surge, MRD FDA guidance speeds label expansion, and strong cash runway. Click for more on LEGN stock.

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

And, if all goes well, over the next five years as well.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...

Local biotech entrepreneurs and investors are seeing signs that the four-year "biotech winter" is finally thawing, though ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.